Haleon plc's latest marketcap:
As of 06/26/2025, Haleon plc's market capitalization has reached $47.11 B. According to our data, Haleon plc is the 461th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 47.11 B |
| Revenue (ttm) | 15.38 B |
| Net Income (ttm) | 1.97 B |
| Shares Out | 8.99 B |
| EPS (ttm) | 0.21 |
| Forward PE | 20.11 |
| Ex-Dividend Date | 04/24/2025 |
| Earnings Date | 07/31/2025 |
Haleon plc's yearly market capitalization.
| Date | Market Cap | Change (%) | Global Rank |
|---|---|---|---|
| 06/26/2025 | £47.11 B | 1.02% | 461 |
| 12/31/2024 | £34.17 B | 15.03% | 449 |
| 12/29/2023 | £29.7 B | -1.74% | 477 |
| 12/30/2022 | £30.23 B | 445 |
Company Profile
About Haleon plc
Haleon plc, together with its subsidiaries, is a global leader in consumer healthcare, specializing in the research, development, manufacture, and sale of a diverse range of products. The company operates across multiple regions, including North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
Product Portfolio
Haleon offers a wide variety of consumer healthcare products under well-known brands:
- Oral Health: Sensodyne, Polident, Parodontax, Aquafresh, and Biotene for toothpastes, mouthwashes, and denture care.
- Vitamins & Supplements: Centrum, Emergen-C, and Caltrate for nutritional support.
- Respiratory Care: Otrivine, Theraflu, and Flonase for cold, flu, and allergy relief.
- Pain Relief: Voltaren, Panadol, and Advil for anti-inflammatory and pain management.
- Digestive Health: TUMS, ENO, and Fenistil for antacids and antihistamine solutions.
Company Background
Originally founded in 1715, Haleon plc was formerly known as DRVW 2022 plc before rebranding in February 2022. The company is headquartered in Weybridge, United Kingdom, and continues to be a trusted name in consumer healthcare worldwide.
Frequently Asked Questions
-
What is Haleon plc's (LON-HLN) current market cap?As of 06/26/2025, Haleon plc (including the parent company, if applicable) has an estimated market capitalization of $47.11 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Haleon plc (LON-HLN) rank globally by market cap?Haleon plc global market capitalization ranking is approximately 461 as of 06/26/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.